Journal Guide

Acta Haematologica is a well-established and internationally recognized clinically oriented journal featuring balanced, wide-ranging coverage of current hematology research. A wealth of information on such problems as anemia, leukemia, lymphoma, multiple myeloma, hereditary disorders, blood coagulation, growth factors, hematopoiesis, and differentiation is contained in first-rate basic and clinical research papers – some of which are accompanied by editorial comments by eminent experts. These are supplemented by short state-of-the-art communications, reviews, and correspondence as well as occasional special issues devoted to “hot topics” in hematology. Cutting-edge clinical information, along translational research relevant to clinical daily life, will keep the practicing hematologist well informed of the new developments in the field.

Acta Haematologica Polonica jest oficjalnym czasopismem Polskiego Towarzystwa Hematologów i Transfuzjologów oraz Instytutu Hematologii i Transfuzjologii zwiazanym z polska hematologia i transfuzjologia od 1970 roku. Pismo publikuje zarówno prace oryginalne doswiadczalne, opisy przypadków jak równiez prace pogladowe i edukacyjne. Tematyka prac publikowanych w Acta Haematologica Polonica obejmuje zagadnienia fizjologii oraz patologii w hematologii i transfuzjologii miedzy innymi dotyczace leukocytów, erytrocytów, plytek krwi, ukladu odpornosciowego, mechanizmów hemostazy oraz aspektów klinicznych rozrostowych chorób hematologicznych.

Acta Oncologica is one of the leading journals in clinical oncology and related disciplines, and accepts articles within all fields of clinical cancer research from applied basic research to cancer nursing and psychological aspects of cancer.

Advances in Hematology is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies in all areas of hematology.

The American Journal of Hematology provides broad coverage of experimental and clinical features of blood diseases in humans and in animal models of human disease. The journal publishes original contributions in non-malignant and malignant hematological diseases including clinical and basic studies in hemostasis and thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports describing novel therapeutic approaches to diagnosis and treatment of hematological diseases are welcomed and encouraged. The journal includes regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, letters and correspondence.

Anemia is a peer-reviewed, open access journal that publishes original research articles, review articles, and clinical studies related to all aspects of anemia.

Annals of Hematology covers the whole spectrum of clinical and experimental hematology, hemostaseology, blood transfusion, and related aspects of medical oncology, including diagnosis and treatment of leukemias, lymphatic neoplasias and solid tumors, and transplantation of hematopoietic stem cells. Coverage includes general aspects of oncology, molecular biology and immunology as pertinent to problems of human blood disease. The journal is associated with the German Society for Hematology and Oncology, and the Austrian Society for Hematology and Oncology. The Editor-in-Chief is Arnold Ganser, Department of Hematology, Hemostasis and Oncology, Medizinische Hochschule Hannover.

Annals of Oncology is devoted to the rapid publication of editorials, reviews, original articles and letters related to oncology, particularly medical oncology. Its character, however, is multidisciplinary, and contributions on clinically-oriented laboratory research, surgery and radiotherapy are assured by the presence of representatives of these disciplines among the Associate Editors and Editorial Board.Annals of Oncology is the official journal of the European Society for Medical Oncology. Since 2008 the Journal is also affiliated with the Japanese Society of Medical Oncology. For more information on this collaboration please click here for the original announcement.Annals of Oncology covers the following areas: * Breast cancer * Gastrointestinal tumours * Lung cancer * Urogenital tumours * Hematologic malignancies * Head and neck cancer * Sarcomas * Gynecologic cancer * Quality of life and supportive care * Phase I studies * Phase II studies * Phase III studies * Translational science.

ATVB is the forum for publication of research on the biology, prevention, and impact of vascular diseases related to arteriosclerosis and thrombosis from a variety of disciplines including biochemistry, biophysics, cell and molecular biology, clinical investigation, epidemiology, genetics, lipoproteins, nutrition, metabolism, and pathology.Online subscriptions are available to members of the American Heart Association/American Stroke Association as a benefit of membership depending on membership level. Members may also qualify for special rates on print subscriptions. Visit My.AmericanHeart.org for more information on membership benefits and to join/renew today!ISI ranks ATVB 4th in Peripheral Vascular Disease and 7th in Hematology Subject Matter Categories (2008 Journal Citation Reports174;, Thomson Reuters, 2009).

BMC Hematology is an open access journal publishing original peer-reviewed research articles in all aspects of the prevention, diagnosis and management of blood disorders, as well as related molecular genetics, pathophysiology, and epidemiology.

Best Practice & Research Clinical Haematology provides a comprehensive review of current clinical practice and thinking within the specialty of haematology.All chapters are commissioned and written by an international team of practising clinicians with the Guest Editors for each issue drawn from a pool of renowned experts and opinion leaders. Reference is made to:• The latest original research• Cochrane Reviews• Audits and confidential enquiries• National and international conferences• National and international guidelines• Personal communicationsAll chapters take the form of practical, evidence-based reviews that seek to address key clinical issues of diagnosis, treatment and patient management.Each issue follows a problem-orientated approach that focuses on the key questions to be addressed, clearly defining what is known and not known. Management will be described in practical terms so that it can be applied to the individual patient.Boxed and bulleted Learning Objectives and Practice Points are features within each chapter and will highlight the core and essential knowledge that will help the physician to provide the best care to their patients.The series' objective is to provide a continuous update for the busy clinician and researcher.

Biology of Blood and Marrow Transplantation publishes original research reports, reviews, editorials, commentaries, letters to the editor, and hypotheses and is the official publication of the American Society for Blood and Marrow Transplantation.The journal focuses on current technology and knowledge in the interdisciplinary field of hematopoetic stem cell transplantation.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Biorheology is an international interdisciplinary journal that publishes research on the deformation and flow properties of biological systems or materials. It is the aim of the editors and publishers of Biorheology to bring together contributions from those working in various fields of biorheological research from all over the world. Members of the editorial board and the advisory board work in different areas of biorheology in several countries where appreciable research activity in this field is being carried out.The aim of biorheological research is to determine and characterize the dynamics of physiological processes at all levels of organization. Manuscripts should report original theoretical and/or experimental research promoting the scientific and technological advances in a broad field that ranges from the rheology of macromolecules and macromolecular arrays to cell, tissue and organ rheology. In all these areas, the interrelationships of rheological properties of the systems or materials investigated and their structural and functional aspects are stressed.The scope of papers solicited by Biorheology extends to systems at different levels of organization that have never been studied before, or, if studied previously, have either never been analyzed in terms of their rheological properties or have not been studied from the point of view of the rheological matching between their structural and functional properties. This biorheological approach applies in particular to molecular studies where changes of physical properties and conformation are investigated without reference to how the process actually takes place, how the forces generated are matched to the properties of the structures and environment concerned, proper time scales, or what structures or strength of structures are required.Biorheology invites papers in which such 'molecular biorheological' aspects, whether in animal or plant systems, are examined and discussed. While we emphasize the biorheology of physiological function in organs and systems, the biorheology of disease is of equal interest. Biorheological analyses of pathological processes and their clinical implications are encouraged, including basic clinical research on hemodynamics and hemorheology.

Blood is a weekly medical journal published by the American Society of Hematology. It was founded by Dr. William Dameshek, the researcher credited with describing the concept of myeloproliferative diseases and participating in the first studies of nitrogen mustard in various blood malignancies, in 1946, and has since been in continuous publication.With 1,364 articles published annually, an impact factor of 10.555, and an Immediacy Index of 2.209, Blood is the most cited peer-reviewed publication in the field. It provides an international forum for the publication of original articles describing basic laboratory, translational, and clinical investigations in hematology. The journal covers all aspects of hematology, including disorders of leukocytes, both benign and malignant, erythrocytes, platelets, hemostatic mechanisms, vascular biology, immunology, and hematologic oncology. All articles undergo a rigorous peer review and are selected on the basis of the originality of the findings, the superior quality of the work described, and the clarity of presentation. Blood is indexed and abstracted by Index Medicus, Excerpta Medica, Current Contents/Life Sciences, Current Contents/Clinical Medicine, Science Citation Index, SCISEARCH, Automatic Subject Citation Alert, ISI/BIOMED, and BIOSIS.

Blood Cancer Journal is a peer-reviewed, online, open access, sister journal to the well-established and highly respected, Leukemia (2011 impact factor 9.561, Journal Citation Reports, Thomson Reuters, 2011), bringing to the fore outstanding pre-clinical and clinical research in the field of hematology, with ramifications into translational biology research down to new therapies. Topics of particular concentration will include, but are not limited to, the following: